Häussinger D, Soboll S, Meijer A J, Gerok W, Tager J M, Sies H
Eur J Biochem. 1985 Nov 4;152(3):597-603. doi: 10.1111/j.1432-1033.1985.tb09237.x.
In livers of fed rats and in perfused livers supplied with a physiological portal glutamine concentration of 0.6 mM, the mitochondrial and cytosolic glutamine concentrations are 20 mM and 7 mM, respectively, thus, the mitochondrial/cytosolic glutamine concentration gradient is 2-3. Uptake and release of glutamine by periportal and perivenous hepatocytes occurs predominantly by an Na+-dependent transport system (so-called system 'N'). Histidine in near-physiological concentrations inhibits both glutamine uptake by periportal hepatocytes and its release by perivenous hepatocytes. This is not due to an inhibition of glutamine-metabolizing enzymes by histidine or its metabolites. With physiological portal glutamine concentrations (0.6 mM), stimulation of glutaminase flux or of glutamine transaminase flux is followed by a decrease of hepatic glutamine levels to about 80% or 30%, respectively, glutamine levels are further decreased to 50% or 20% in the presence of histidine. When glutamine is synthesized endogenously (no glutamine added), the histidine-induced inhibition of glutamine release is paralleled by a 210% increase of the hepatic tissue level of glutamine. In experiments with and without methionine sulfoximine and in the absence of added glutamine, the glutamine content in the small perivenous hepatocyte population containing glutamine synthetase is estimated to be about 3.5 mumol/g wet weight and that in the periportal hepatocytes as low as 0.1 mumol/g wet weight. In contrast to the prevailing view, it is concluded that glutamine transport across the plasma membrane of hepatocytes is a potential regulatory site in glutamine degradation and synthesis, especially under the influence of effectors like histidine.
在喂食大鼠的肝脏以及灌注有生理门静脉谷氨酰胺浓度(0.6 mM)的肝脏中,线粒体和胞质中的谷氨酰胺浓度分别为20 mM和7 mM,因此,线粒体/胞质谷氨酰胺浓度梯度为2 - 3。门静脉周围和肝静脉周围肝细胞对谷氨酰胺的摄取和释放主要通过一种依赖钠离子的转运系统(所谓的“N系统”)进行。接近生理浓度的组氨酸会抑制门静脉周围肝细胞对谷氨酰胺的摄取以及肝静脉周围肝细胞对谷氨酰胺的释放。这并非是由于组氨酸或其代谢产物对谷氨酰胺代谢酶的抑制作用。在生理门静脉谷氨酰胺浓度(0.6 mM)下,谷氨酰胺酶通量或谷氨酰胺转氨酶通量受到刺激后,肝脏谷氨酰胺水平分别下降至约80%或30%,在存在组氨酸的情况下,谷氨酰胺水平进一步下降至50%或20%。当内源性合成谷氨酰胺(不添加谷氨酰胺)时,组氨酸诱导的谷氨酰胺释放抑制伴随着肝脏组织谷氨酰胺水平增加210%。在有和没有甲硫氨酸亚砜亚胺的实验中,且在不添加谷氨酰胺的情况下,含有谷氨酰胺合成酶的小肝静脉周围肝细胞群体中的谷氨酰胺含量估计约为3.5 μmol/g湿重,而门静脉周围肝细胞中的谷氨酰胺含量低至0.1 μmol/g湿重。与普遍观点相反,得出的结论是,谷氨酰胺跨肝细胞质膜的转运是谷氨酰胺降解和合成中的一个潜在调节位点,尤其是在组氨酸等效应物的影响下。